Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Director's Forum"'
Publikováno v:
Hosp Pharm
The relentless surges of global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections that caused the Covid-19 disease had pressured researchers and regulators to develop effective treatments quickly. While studying these therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00d4a24e96566b9c7db352864c5a5a6
https://doi.org/10.1177/00185787211037545
https://doi.org/10.1177/00185787211037545
Autor:
Lauren Stanz, Robert J. Weber
Publikováno v:
Hosp Pharm
Background: COVID-19 disease as caused by a coronavirus called SARS-CoV-2 has taken the world by storm with upwards of 8 million confirmed infections in more than 190 countries. At the writing of this article, over 2 million Americans are confirmed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7b92877c64c712ab6f90f94a863efd
https://doi.org/10.1177/0018578720936589
https://doi.org/10.1177/0018578720936589
Publikováno v:
Hosp Pharm
Background: A safe medication error reporting culture is one that promotes, fosters, and rewards the reporting of errors and events across the spectrum of harm (none to significant harm). For this culture to develop, leaders must key department cultu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0973f01fbc80ea2a8d1c814d9348c413
https://pubmed.ncbi.nlm.nih.gov/34720167
https://pubmed.ncbi.nlm.nih.gov/34720167
Publikováno v:
Hosp Pharm
Background: Maintaining integrity of the pharmaceutical supply chain is critical to providing medications that are free from adulteration (counterfeit, substandard or unapproved medications), making them safe for patient use. Purchasing pharmaceutica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e689896473656de44b1744b5c3546c02
https://doi.org/10.1177/0018578719868406
https://doi.org/10.1177/0018578719868406
Autor:
Phuoc Anh Anne Nguyen, Elizabeth Ann Casserly, Melanie K. Kuester, Luke Miller, Robert J. Weber, Daniel A. Lewis, Leigh E. Efird, Matthew J. Gibson, Patricia Masters
Publikováno v:
Hosp Pharm
Background: Opioid use is classified as an epidemic by many due to the impact of these medications on society. Federal and state laws for prescribing and dispensing opioids have changed rapidly in a short period of time to hopefully balance proper pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf99e835057f25f0bd8409304d362c2
https://doi.org/10.1177/0018578719868408
https://doi.org/10.1177/0018578719868408
Publikováno v:
Hosp Pharm
Objective: To provide lessons learned for colleges of pharmacy and large health systems that are contemplating or in the process of undergoing integration. Method: This report describes the merger of an academic medical center and large health system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c433cefea062c900efe33af4e351bf3
https://doi.org/10.1177/0018578718823735
https://doi.org/10.1177/0018578718823735
Autor:
Nicholas P. Gazda, Kasey Hamrick, Robert P. Granko, Jordan Baskett, Meghan M. Mellon, Stephen F. Eckel, Emily Griffin
Publikováno v:
Hospital Pharmacy. 53:96-100
Purpose: The purpose of this article is to share experiences after the development of a health-system pharmacy administration residency with a MS degree and express the need for additional programs in nonacademic medical center health-system settings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2390569ae0d8ad33934e96c063c861
https://doi.org/10.1177/0018578718756659
https://doi.org/10.1177/0018578718756659
Publikováno v:
Hospital Pharmacy. 52:155-159
As spending on medications in the United States increases with each passing year, the need for drug pricing transparency by manufacturers also increases. Drug spending, excluding rebates and discounts, was $309.5 billion in 2015, up 8.5% from 2014. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e18ed09159161c1a4bab5d573343c95d
https://doi.org/10.1310/hpj5202-155
https://doi.org/10.1310/hpj5202-155
Publikováno v:
Hospital Pharmacy. 51:944-949
The changing landscape of health care mirrors that of health-system pharmacy, with pharmacists' scope of practice and provider status being the most significant changes. This creates new roles and opportunities; many of these roles are considered to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff85b5f9395e5f1d37e0a3238b3b0a6f
https://doi.org/10.1310/hpj5111-944
https://doi.org/10.1310/hpj5111-944
Publikováno v:
Hospital Pharmacy. 51:856-862
Critical care medicine has grown from a small group of physicians participating in patient care rounds in surgical and medical intensive care units (ICUs) to a highly technical, interdisciplinary team. Pharmacy's growth in the area of critical care i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461ecf1e22a4b523d4da80139b1b0d53
https://doi.org/10.1310/hpj5110-856
https://doi.org/10.1310/hpj5110-856